These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 21349013)

  • 21. Dynamic balancing randomization in controlled clinical trials.
    Heritier S; Gebski V; Pillai A
    Stat Med; 2005 Dec; 24(24):3729-41. PubMed ID: 16320277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomization with a posteriori constraints: description and properties.
    Gicquel S; Marion-Gallois R
    Stat Med; 2007 Nov; 26(27):5033-45. PubMed ID: 17721873
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Using scratch card technology for random allocation concealment in a clinical trial with a crossover design.
    Beksinska ME; Joanis C; Smit JA; Pienaar J; Piaggio G
    Clin Trials; 2013 Feb; 10(1):125-30. PubMed ID: 23188890
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The methodologic quality of randomization as assessed from reports of trials in specialist and general medical journals.
    Schulz KF; Chalmers I; Altman DG; Grimes DA; Doré CJ
    Online J Curr Clin Trials; 1995 Aug; Doc No 197():[81 paragraphs]. PubMed ID: 8542098
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statistical comparison of random allocation methods in cancer clinical trials.
    Hagino A; Hamada C; Yoshimura I; Ohashi Y; Sakamoto J; Nakazato H
    Control Clin Trials; 2004 Dec; 25(6):572-84. PubMed ID: 15588744
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of risk of bias in randomized clinical trials in surgery.
    Gurusamy KS; Gluud C; Nikolova D; Davidson BR
    Br J Surg; 2009 Apr; 96(4):342-9. PubMed ID: 19283747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some practical problems in implementing randomization.
    Downs M; Tucker K; Christ-Schmidt H; Wittes J
    Clin Trials; 2010 Jun; 7(3):235-45. PubMed ID: 20484491
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adaptive biased urn randomization in small strata when blinding is impossible.
    Schouten HJ
    Biometrics; 1995 Dec; 51(4):1529-35. PubMed ID: 8589238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantifying the magnitude of baseline covariate imbalances resulting from selection bias in randomized clinical trials.
    Berger VW
    Biom J; 2005 Apr; 47(2):119-27; discussion 128-39. PubMed ID: 16389910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dynamic treatment allocation adjusting for prognostic factors for more than two treatments.
    Dror S; Faraggi D; Reiser B
    Biometrics; 1995 Dec; 51(4):1338-43. PubMed ID: 8589225
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reporting of methods for reducing and detecting bias: an example from the WHO Misoprostol Third Stage of Labour equivalence randomised controlled trial.
    Piaggio G; Elbourne D; Schulz KF; Villar J; Pinol AP; Gülmezoglu AM;
    BMC Med Res Methodol; 2003 Oct; 3():19. PubMed ID: 14525622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjusting for observable selection bias in block randomized trials.
    Ivanova A; Barrier RC; Berger VW
    Stat Med; 2005 May; 24(10):1537-46. PubMed ID: 15723426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The pursuit of balance: An overview of covariate-adaptive randomization techniques in clinical trials.
    Lin Y; Zhu M; Su Z
    Contemp Clin Trials; 2015 Nov; 45(Pt A):21-5. PubMed ID: 26244705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selection bias, allocation concealment and randomization design in clinical trials.
    Zhao W
    Contemp Clin Trials; 2013 Sep; 36(1):263-5. PubMed ID: 23871796
    [No Abstract]   [Full Text] [Related]  

  • 35. Pseudo cluster randomization performed well when used in practice.
    Melis RJ; Teerenstra S; Rikkert MG; Borm GF
    J Clin Epidemiol; 2008 Nov; 61(11):1169-75. PubMed ID: 18550331
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of randomization techniques for clinical trials with data from the HOMERUS-trial.
    Verberk WJ; Kroon AA; Kessels AG; Nelemans PJ; Van Ree JW; Lenders JW; Thien T; Bakx JC; Van Montfrans GA; Smit AJ; Beltman FW; De Leeuw PW
    Blood Press; 2005; 14(5):306-14. PubMed ID: 16257877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Randomised phase II trials in oncology].
    Piedbois P
    Bull Cancer; 2007 Nov; 94(11):953-6. PubMed ID: 18055312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cross-trial networking in AML: a step forward rather than corner cutting.
    Büchner T; Döhner H; Ehninger G; Ganser A; Niederwieser D; Hasford J
    Leuk Res; 2004 Jun; 28(6):649-50. PubMed ID: 15120943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of minimization in clinical trials.
    Taves DR
    Contemp Clin Trials; 2010 Mar; 31(2):180-4. PubMed ID: 20060500
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expansion of the modified Zelen's approach randomization and dynamic randomization with partial block supplies at the centers to unequal allocation.
    Kuznetsova OM; Tymofyeyev Y
    Contemp Clin Trials; 2011 Nov; 32(6):962-72. PubMed ID: 21888990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.